Bioasis Technologies Inc.
BTI
Ранг среди акций
#39864
Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused... Bioasis Technologies Inc. is a development-stage biopharmaceutical firm focused on innovating diagnostic methods and therapeutic solutions for a range of neurological conditions. The company's primary technological asset is the xB3 platform, engineered to enable the transport of medicinal compounds across the often-impenetrable blood-brain barrier. This capability is crucial for addressing central nervous system disorders, including various brain cancers, metabolic dysfunctions, and neurodegenerative illnesses. Bioasis is actively advancing its in-house pipeline with programs such as xB3-001 for brain metastases, xB3-002 for glioblastoma, and xB3-007 for neurodegenerative diseases, all designed to offer both symptomatic relief and disease-modifying benefits. The company has also established numerous strategic alliances. These include a partnership with Aposense Limited to deliver siRNA therapeutics for CNS disorders; a collaboration with Oxyrane UK Ltd. to combine the xB3 technology with Oxyrane's OxyCAT platform for enhanced enzyme replacement therapy targeting the brain; an agreement with Janssen Biotech, Inc. for the discovery, development, and commercialization of novel products leveraging the xB3 platform; and a research and licensing deal with Neuramedy Co Ltd. to develop and market an xB3-enhanced version of their antibody, Tomaralimab. Founded in 2006, Bioasis Technologies Inc. is headquartered in New Haven, Connecticut.
Цена акции
$0.00366968
Последняя синхронизация: 2024-07-23
Рыночная капитализация
$291.42K
Изменение (1 день)
-0.81%
Изменение (1 год)
1,734.84%
Страна
US
Торговля Bioasis Technologies Inc. (BTI)
Категория
Healthcare
Рыночная капитализация Bioasis Technologies Inc.(BTI)
Рыночная капитализация: $291.42K
По состоянию на October 2026 рыночная капитализация Bioasis Technologies Inc. составляет $291.42K. Согласно нашим данным, Bioasis Technologies Inc. занимает 39864th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Bioasis Technologies Inc. с 2010 по 2026
BTI по сравнению с пятеркой самых популярных stocks
| Цена за BTI | Актив Б | Рыночная капитализация B | результаты | |
|---|---|---|---|---|
$65,067.88
$7.94K
|
$5.167T | +65,067,875,482.42% | ||
|
$63,150.47
$7.94K
|
$5.015T | +63,150,474,156.39% | ||
|
$51,736.59
$7.94K
|
$4.108T | +51,736,585,054.77% | ||
|
$49,136.18
$7.94K
|
$3.902T | +49,136,176,181.32% | ||
|
$33,867.98
$7.94K
|
$2.689T | +33,867,976,754.30% |
